HEADER TRANSCRIPTION 16-AUG-00 1FM9
TITLE THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF
TITLE 2 THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY
TITLE 3 BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR
TITLE 4 PEPTIDES.
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: RETINOIC ACID RECEPTOR RXR-ALPHA;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN - RESIDUES 225 - 462;
COMPND 5 ENGINEERED: YES;
COMPND 6 MOL_ID: 2;
COMPND 7 MOLECULE: PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
COMPND 8 CHAIN: D;
COMPND 9 FRAGMENT: LIGAND BINDING DOMAIN - RESIDUES 206 - 477;
COMPND 10 ENGINEERED: YES;
COMPND 11 MOL_ID: 3;
COMPND 12 MOLECULE: STEROID RECEPTOR COACTIVATOR;
COMPND 13 CHAIN: B, E;
COMPND 14 FRAGMENT: SRC-1 PEPTIDE;
COMPND 15 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PACYC184;
SOURCE 10 MOL_ID: 2;
SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 12 ORGANISM_COMMON: HUMAN;
SOURCE 13 ORGANISM_TAXID: 9606;
SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 17 EXPRESSION_SYSTEM_VECTOR: PLASMID;
SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PRSET;
SOURCE 19 MOL_ID: 3;
SOURCE 20 SYNTHETIC: YES;
SOURCE 21 OTHER_DETAILS: CHEMICALLY SYNTHESIZED 25MER PORTION OF HUMAN SRC-1
SOURCE 22 COACTIVATOR PEPTIDE
KEYWDS THE HETERODIMER OF THE NUCLEAR RECEPTOR LIGAND BINDING DOMAINS OF
KEYWDS 2 RXRALPHA AND PPARGAMMA BOUND RESPECTIVELY WITH 9-CIS RETINOIC ACID
KEYWDS 3 AND GI262570 AND CO-ACTIVATOR PEPTIDES, TRANSCRIPTION
EXPDTA X-RAY DIFFRACTION
AUTHOR R.T.GAMPE JR.,V.G.MONTANA,M.H.LAMBERT,A.B.MILLER,R.K.BLEDSOE,
AUTHOR 2 M.V.MILBURN,S.A.KLIEWER,T.M.WILLSON,H.E.XU
REVDAT 6 07-FEB-24 1FM9 1 REMARK HETSYN
REVDAT 5 31-JAN-18 1FM9 1 REMARK
REVDAT 4 04-OCT-17 1FM9 1 REMARK
REVDAT 3 26-DEC-12 1FM9 1 HET HETNAM VERSN
REVDAT 2 24-FEB-09 1FM9 1 VERSN
REVDAT 1 16-FEB-01 1FM9 0
JRNL AUTH R.T.GAMPE JR.,V.G.MONTANA,M.H.LAMBERT,A.B.MILLER,
JRNL AUTH 2 R.K.BLEDSOE,M.V.MILBURN,S.A.KLIEWER,T.M.WILLSON,H.E.XU
JRNL TITL ASYMMETRY IN THE PPARGAMMA/RXRALPHA CRYSTAL STRUCTURE
JRNL TITL 2 REVEALS THE MOLECULAR BASIS OF HETERODIMERIZATION AMONG
JRNL TITL 3 NUCLEAR RECEPTORS.
JRNL REF MOL.CELL V. 5 545 2000
JRNL REFN ISSN 1097-2765
JRNL PMID 10882139
JRNL DOI 10.1016/S1097-2765(00)80448-7
REMARK 2
REMARK 2 RESOLUTION. 2.10 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS 0.5
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 149063.170
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.8
REMARK 3 NUMBER OF REFLECTIONS : 29087
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.239
REMARK 3 FREE R VALUE : 0.268
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000
REMARK 3 FREE R VALUE TEST SET COUNT : 2895
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.50
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3820
REMARK 3 BIN R VALUE (WORKING SET) : 0.3080
REMARK 3 BIN FREE R VALUE : 0.3340
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.40
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 444
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4148
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 63
REMARK 3 SOLVENT ATOMS : 131
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 25.30
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.00
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -3.73000
REMARK 3 B22 (A**2) : 6.42000
REMARK 3 B33 (A**2) : -2.69000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28
REMARK 3 ESD FROM SIGMAA (A) : 0.27
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.33
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.30
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.013
REMARK 3 BOND ANGLES (DEGREES) : 1.600
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.40
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.960
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 1.200 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.140 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 1.410 ; 2.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.220 ; 2.500
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : FLAT MODEL
REMARK 3 KSOL : 0.38
REMARK 3 BSOL : 55.00
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : BSXPI3.XPL
REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 4 : 570.XPL
REMARK 3 PARAMETER FILE 5 : 9CRA3.XPL
REMARK 3 PARAMETER FILE 6 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : NULL
REMARK 3 TOPOLOGY FILE 3 : NULL
REMARK 3 TOPOLOGY FILE 4 : NULL
REMARK 3 TOPOLOGY FILE 5 : NULL
REMARK 3 TOPOLOGY FILE 6 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1FM9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-SEP-00.
REMARK 100 THE DEPOSITION ID IS D_1000011709.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 01-DEC-99
REMARK 200 TEMPERATURE (KELVIN) : 93
REMARK 200 PH : 7.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25483
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100
REMARK 200 RESOLUTION RANGE LOW (A) : 20.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : 0.09400
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.2000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: X-PLOR
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 40.72
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 17% PEG 4K, 200MM NASCN, 8% ETHYLENE
REMARK 280 GLYCOL , PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 22K,
REMARK 280 TEMPERATURE 295.0K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.07150
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 105.57450
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.02300
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 105.57450
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.07150
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.02300
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D, B, E
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 SER A 225
REMARK 465 ALA A 226
REMARK 465 HIS A 459
REMARK 465 GLN A 460
REMARK 465 MET A 461
REMARK 465 THR A 462
REMARK 465 CYS B 619
REMARK 465 PRO B 620
REMARK 465 SER B 621
REMARK 465 SER B 622
REMARK 465 HIS B 623
REMARK 465 SER B 624
REMARK 465 SER B 625
REMARK 465 LEU B 626
REMARK 465 THR B 627
REMARK 465 GLU B 628
REMARK 465 ARG B 629
REMARK 465 GLY B 640
REMARK 465 SER B 641
REMARK 465 PRO B 642
REMARK 465 SER B 643
REMARK 465 CYS E 676
REMARK 465 PRO E 677
REMARK 465 SER E 678
REMARK 465 SER E 679
REMARK 465 HIS E 680
REMARK 465 SER E 681
REMARK 465 SER E 682
REMARK 465 LEU E 683
REMARK 465 THR E 684
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ASN A 227 CG OD1 ND2
REMARK 470 LYS A 245 CB CG CD CE NZ
REMARK 470 THR A 246 CB OG1 CG2
REMARK 470 GLU A 247 CB CG CD OE1 OE2
REMARK 470 THR A 248 CB OG1 CG2
REMARK 470 TYR A 249 CB CG CD1 CD2 CE1 CE2 CZ
REMARK 470 TYR A 249 OH
REMARK 470 VAL A 250 CB CG1 CG2
REMARK 470 GLU A 251 CB CG CD OE1 OE2
REMARK 470 ALA A 252 CB
REMARK 470 ASN A 253 CB CG OD1 ND2
REMARK 470 MET A 254 CB CG SD CE
REMARK 470 LEU A 256 CB CG CD1 CD2
REMARK 470 ASN A 257 CB CG OD1 ND2
REMARK 470 PRO A 258 CB CG CD
REMARK 470 SER A 259 CB OG
REMARK 470 SER A 260 CB OG
REMARK 470 PRO A 261 CB CG CD
REMARK 470 ASN A 262 CB CG OD1 ND2
REMARK 470 ASP A 263 CB CG OD1 OD2
REMARK 470 PRO D 206 CG CD
REMARK 470 GLN D 271 CG CD OE1 NE2
REMARK 470 LYS B 631 CG CD CE NZ
REMARK 470 LYS E 688 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 PRO A 244 C - N - CA ANGL. DEV. = 21.6 DEGREES
REMARK 500 PRO A 244 C - N - CD ANGL. DEV. = -23.5 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP A 229 -59.71 80.27
REMARK 500 GLU A 243 -135.31 -67.36
REMARK 500 PRO A 244 -149.01 39.63
REMARK 500 LYS A 245 58.91 84.08
REMARK 500 THR A 246 147.60 81.29
REMARK 500 GLU A 247 -65.45 75.77
REMARK 500 THR A 248 1.52 -58.40
REMARK 500 TYR A 249 55.08 -113.34
REMARK 500 VAL A 250 -13.29 -158.41
REMARK 500 ALA A 252 54.53 -149.49
REMARK 500 ASN A 253 -10.51 -144.84
REMARK 500 MET A 254 -2.76 -158.49
REMARK 500 LEU A 256 -143.90 89.21
REMARK 500 ASN A 257 88.73 125.01
REMARK 500 SER A 259 -120.37 97.20
REMARK 500 SER A 260 29.15 128.45
REMARK 500 ASN A 262 72.88 -106.10
REMARK 500 ASP A 263 111.28 176.64
REMARK 500 HIS A 288 -7.33 76.68
REMARK 500 ASP A 322 54.82 27.40
REMARK 500 ALA A 344 -65.78 72.75
REMARK 500 ASN A 385 81.32 -152.94
REMARK 500 LYS A 440 -52.33 -127.53
REMARK 500 LEU A 441 42.96 -74.72
REMARK 500 ILE A 442 -18.94 -167.00
REMARK 500 ASP A 444 94.97 63.47
REMARK 500 THR A 445 79.76 60.82
REMARK 500 PRO A 446 -175.54 -48.79
REMARK 500 ILE A 447 -152.02 -106.89
REMARK 500 PHE A 450 -61.68 90.85
REMARK 500 ALA A 457 136.14 66.71
REMARK 500 ASP D 243 84.05 155.39
REMARK 500 LYS D 244 144.03 31.38
REMARK 500 LYS D 265 -138.43 -78.30
REMARK 500 ILE D 267 94.01 -51.47
REMARK 500 GLN D 271 144.06 61.89
REMARK 500 GLN D 273 -126.04 43.02
REMARK 500 SER D 274 -31.47 66.79
REMARK 500 GLU D 276 170.31 30.18
REMARK 500 LYS D 358 -117.94 6.67
REMARK 500 SER D 464 85.64 57.27
REMARK 500 LEU D 476 -127.20 -97.83
REMARK 500 ARG E 686 -66.78 67.72
REMARK 500 PRO E 699 -168.71 -61.61
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 GI262570 IS A SYNTHETIC ANTIDIABETIC AGONIST FOR PPARGAMMA
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 570 D 200
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9CR A 201
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1FM6 RELATED DB: PDB
REMARK 900 1FM6 CONTAINS THE SAME PROTEIN COMPLEXED WITH ANOTHER SYNTHETIC
REMARK 900 ANTIDIABETIC AGONIST.
DBREF 1FM9 A 225 462 UNP P19793 RXRA_HUMAN 225 462
DBREF 1FM9 D 206 477 UNP P37231 PPARG_HUMAN 234 505
DBREF 1FM9 B 619 643 UNP O43793 O43793 675 701
DBREF 1FM9 E 676 700 UNP O43793 O43793 675 701
SEQRES 1 A 238 SER ALA ASN GLU ASP MET PRO VAL GLU ARG ILE LEU GLU
SEQRES 2 A 238 ALA GLU LEU ALA VAL GLU PRO LYS THR GLU THR TYR VAL
SEQRES 3 A 238 GLU ALA ASN MET GLY LEU ASN PRO SER SER PRO ASN ASP
SEQRES 4 A 238 PRO VAL THR ASN ILE CYS GLN ALA ALA ASP LYS GLN LEU
SEQRES 5 A 238 PHE THR LEU VAL GLU TRP ALA LYS ARG ILE PRO HIS PHE
SEQRES 6 A 238 SER GLU LEU PRO LEU ASP ASP GLN VAL ILE LEU LEU ARG
SEQRES 7 A 238 ALA GLY TRP ASN GLU LEU LEU ILE ALA SER PHE SER HIS
SEQRES 8 A 238 ARG SER ILE ALA VAL LYS ASP GLY ILE LEU LEU ALA THR
SEQRES 9 A 238 GLY LEU HIS VAL HIS ARG ASN SER ALA HIS SER ALA GLY
SEQRES 10 A 238 VAL GLY ALA ILE PHE ASP ARG VAL LEU THR GLU LEU VAL
SEQRES 11 A 238 SER LYS MET ARG ASP MET GLN MET ASP LYS THR GLU LEU
SEQRES 12 A 238 GLY CYS LEU ARG ALA ILE VAL LEU PHE ASN PRO ASP SER
SEQRES 13 A 238 LYS GLY LEU SER ASN PRO ALA GLU VAL GLU ALA LEU ARG
SEQRES 14 A 238 GLU LYS VAL TYR ALA SER LEU GLU ALA TYR CYS LYS HIS
SEQRES 15 A 238 LYS TYR PRO GLU GLN PRO GLY ARG PHE ALA LYS LEU LEU
SEQRES 16 A 238 LEU ARG LEU PRO ALA LEU ARG SER ILE GLY LEU LYS CYS
SEQRES 17 A 238 LEU GLU HIS LEU PHE PHE PHE LYS LEU ILE GLY ASP THR
SEQRES 18 A 238 PRO ILE ASP THR PHE LEU MET GLU MET LEU GLU ALA PRO
SEQRES 19 A 238 HIS GLN MET THR
SEQRES 1 D 272 PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU
SEQRES 2 D 272 TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA
SEQRES 3 D 272 LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS
SEQRES 4 D 272 SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU MET MET
SEQRES 5 D 272 GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU
SEQRES 6 D 272 GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN
SEQRES 7 D 272 GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE
SEQRES 8 D 272 THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU
SEQRES 9 D 272 ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL
SEQRES 10 D 272 HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU MET ASN
SEQRES 11 D 272 LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET
SEQRES 12 D 272 THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY
SEQRES 13 D 272 ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE
SEQRES 14 D 272 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE
SEQRES 15 D 272 ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU
SEQRES 16 D 272 LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU
SEQRES 17 D 272 LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO
SEQRES 18 D 272 GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET
SEQRES 19 D 272 THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU
SEQRES 20 D 272 LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SER LEU
SEQRES 21 D 272 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR
SEQRES 1 B 25 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS
SEQRES 2 B 25 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER
SEQRES 1 E 25 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS
SEQRES 2 E 25 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER
HET 9CR A 201 22
HET 570 D 200 41
HETNAM 9CR (9CIS)-RETINOIC ACID
HETNAM 570 2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-
HETNAM 2 570 OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID
HETSYN 570 GI262570; FARGLITAZAR
FORMUL 5 9CR C20 H28 O2
FORMUL 6 570 C34 H30 N2 O5
FORMUL 7 HOH *131(H2 O)
HELIX 1 1 PRO A 231 VAL A 242 1 12
HELIX 2 2 ASP A 263 ARG A 285 1 23
HELIX 3 3 PRO A 293 SER A 317 1 25
HELIX 4 4 ILE A 318 VAL A 320 5 3
HELIX 5 5 ARG A 334 ALA A 340 1 7
HELIX 6 6 ALA A 344 LEU A 353 1 10
HELIX 7 7 LEU A 353 GLN A 361 1 9
HELIX 8 8 ASP A 363 PHE A 376 1 14
HELIX 9 9 ASN A 385 TYR A 408 1 24
HELIX 10 10 GLY A 413 LEU A 420 1 8
HELIX 11 11 ARG A 421 PHE A 437 1 17
HELIX 12 12 PHE A 450 LEU A 455 1 6
HELIX 13 13 GLU D 207 PHE D 226 1 20
HELIX 14 14 THR D 229 GLY D 239 1 11
HELIX 15 15 ASP D 251 PHE D 264 1 14
HELIX 16 16 GLU D 276 SER D 302 1 27
HELIX 17 17 GLY D 305 LEU D 309 5 5
HELIX 18 18 ASP D 310 LEU D 333 1 24
HELIX 19 19 ARG D 350 SER D 355 1 6
HELIX 20 20 PRO D 359 PHE D 363 5 5
HELIX 21 21 MET D 364 ALA D 376 1 13
HELIX 22 22 ASP D 380 LEU D 393 1 14
HELIX 23 23 ASN D 402 HIS D 425 1 24
HELIX 24 24 GLN D 430 GLU D 460 1 31
HELIX 25 25 HIS D 466 LYS D 474 1 9
HELIX 26 26 HIS B 630 GLN B 638 1 9
HELIX 27 27 HIS E 687 GLU E 696 1 10
SHEET 1 A 2 GLY A 323 LEU A 325 0
SHEET 2 A 2 HIS A 331 HIS A 333 -1 N VAL A 332 O ILE A 324
SHEET 1 B 4 PHE D 247 ILE D 249 0
SHEET 2 B 4 GLY D 346 THR D 349 1 O PHE D 347 N ILE D 249
SHEET 3 B 4 GLY D 338 ILE D 341 -1 O VAL D 339 N MET D 348
SHEET 4 B 4 MET D 334 ASN D 335 -1 N ASN D 335 O GLY D 338
CISPEP 1 GLU A 243 PRO A 244 0 0.46
SITE 1 AC1 18 HOH D 63 ARG D 280 PHE D 282 GLY D 284
SITE 2 AC1 18 CYS D 285 GLN D 286 SER D 289 HIS D 323
SITE 3 AC1 18 TYR D 327 LEU D 330 ILE D 341 MET D 348
SITE 4 AC1 18 PHE D 360 MET D 364 HIS D 449 LEU D 465
SITE 5 AC1 18 LEU D 469 TYR D 473
SITE 1 AC2 10 ALA A 271 GLN A 275 TRP A 305 PHE A 313
SITE 2 AC2 10 ARG A 316 LEU A 326 ALA A 327 CYS A 432
SITE 3 AC2 10 HIS A 435 LEU A 436
CRYST1 46.143 54.046 211.149 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.021672 0.000000 0.000000 0.00000
SCALE2 0.000000 0.018503 0.000000 0.00000
SCALE3 0.000000 0.000000 0.004736 0.00000